Variant report

Variant	esv1798659
Chromosome Location	chr16:47083332-47234379
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2154)
CpG islands
(count:1282)
Chromatin interactive
region (count:66)
LncRNA
region (count:9)
Mature miRNA
region (count: 0)
miRNA target
sites (count:5)

(count:2154 , 50 per page) page: 1 2 3 4 5 6 7 ... 44

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:47180937-47181312	K562	blood:	n/a	n/a
2	ARID3A	chr16:47216266-47216628	HepG2	liver:	n/a	n/a
3	ARID3A	chr16:47177086-47177176	HepG2	liver:	n/a	n/a
4	ARID3A	chr16:47092472-47093002	HepG2	liver:	n/a	n/a
5	ARID3A	chr16:47176783-47176815	K562	blood:	n/a	n/a
6	ARID3A	chr16:47196782-47196800	HepG2	liver:	n/a	n/a
7	ARID3A	chr16:47166225-47166502	K562	blood:	n/a	n/a
8	ARID3A	chr16:47175602-47176202	K562	blood:	n/a	n/a
9	ARID3A	chr16:47175635-47176566	HepG2	liver:	n/a	n/a
10	ARID3A	chr16:47169900-47170121	K562	blood:	n/a	n/a
11	ARID3A	chr16:47177441-47177480	K562	blood:	n/a	n/a
12	ARID3A	chr16:47171892-47172010	K562	blood:	n/a	n/a
13	ARID3A	chr16:47178303-47178477	HepG2	liver:	n/a	n/a
14	ATF1	chr16:47197545-47197587	K562	blood:	n/a	n/a
15	ATF1	chr16:47170098-47170312	K562	blood:	n/a	n/a
16	ATF1	chr16:47175658-47176054	K562	blood:	n/a	n/a
17	ATF2	chr16:47176226-47176738	GM12878	blood:	n/a	n/a
18	ATF2	chr16:47175571-47176087	GM12878	blood:	n/a	n/a
19	ATF2	chr16:47175531-47176062	GM12878	blood:	n/a	n/a
20	ATF2	chr16:47176142-47176695	GM12878	blood:	n/a	n/a
21	ATF3	chr16:47171874-47172117	K562	blood:	n/a	n/a
22	ATF3	chr16:47177260-47177528	K562	blood:	n/a	n/a
23	BACH1	chr16:47152449-47152458	K562	blood:	n/a	n/a
24	BACH1	chr16:47175631-47176087	H1-hESC	embryonic stem cell:	n/a	n/a
25	BACH1	chr16:47176731-47177908	H1-hESC	embryonic stem cell:	n/a	n/a
26	BACH1	chr16:47178178-47178180	H1-hESC	embryonic stem cell:	n/a	n/a
27	BATF	chr16:47176399-47176669	GM12878	blood:	n/a	n/a
28	BATF	chr16:47176365-47176663	GM12878	blood:	n/a	n/a
29	BATF	chr16:47175661-47175976	GM12878	blood:	n/a	n/a
30	BATF	chr16:47147784-47148314	GM12878	blood:	n/a	n/a
31	BCL11A	chr16:47176367-47176707	GM12878	blood:	n/a	n/a
32	BCLAF1	chr16:47177145-47177707	GM12878	blood:	n/a	chr16:47177425-47177438 chr16:47177593-47177602 chr16:47177563-47177572
33	BCLAF1	chr16:47175480-47176190	GM12878	blood:	n/a	n/a
34	BCLAF1	chr16:47175544-47176047	GM12878	blood:	n/a	n/a
35	BCLAF1	chr16:47177271-47177669	GM12878	blood:	n/a	chr16:47177425-47177438 chr16:47177593-47177602 chr16:47177563-47177572
36	BCLAF1	chr16:47176319-47176951	GM12878	blood:	n/a	n/a
37	BHLHE40	chr16:47177272-47178380	K562	blood:	n/a	chr16:47178152-47178168 chr16:47177449-47177465 chr16:47178004-47178020 chr16:47178144-47178160
38	BHLHE40	chr16:47175534-47176602	GM12878	blood:	n/a	n/a
39	BHLHE40	chr16:47176815-47178581	GM12878	blood:	n/a	chr16:47178152-47178168 chr16:47176993-47177009 chr16:47176944-47176960 chr16:47177449-47177465 chr16:47178004-47178020 chr16:47178144-47178160
40	BHLHE40	chr16:47087017-47087029	HepG2	liver:	n/a	n/a
41	BHLHE40	chr16:47177335-47177732	HepG2	liver:	n/a	chr16:47177449-47177465
42	BHLHE40	chr16:47175636-47176200	K562	blood:	n/a	n/a
43	BRCA1	chr16:47178549-47178596	HepG2	liver:	n/a	n/a
44	BRCA1	chr16:47164027-47164063	GM12878	blood:	n/a	n/a
45	BRCA1	chr16:47176374-47176777	Hela-S3	cervix:	n/a	n/a
46	BRCA1	chr16:47178424-47178462	GM12878	blood:	n/a	n/a
47	BRCA1	chr16:47175537-47175997	Hela-S3	cervix:	n/a	n/a
48	CBX3	chr16:47178273-47178641	K562	blood:	n/a	n/a
49	CBX3	chr16:47177298-47177690	K562	blood:	n/a	n/a
50	CBX3	chr16:47186439-47186720	K562	blood:	n/a	n/a

(count:1282 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:47177175-47177225	HCPEpiC	choroid plexus:	n/a
2	chr16:47177175-47177225	HCPEpiC	choroid plexus:	n/a
3	chr16:47178357-47178407	HL-60	blood:	n/a
4	chr16:47178357-47178407	HUVEC	blood vessel:	n/a
5	chr16:47175842-47175892	HRCEpiC	kidney:	n/a
6	chr16:47178070-47178120	AoSMC	blood vessel:	n/a
7	chr16:47176710-47176760	AG04450	lung:	fetal
8	chr16:47177480-47177530	HCT-116	colon:	n/a
9	chr16:47175936-47175986	MCF-7	breast:	n/a
10	chr16:47216988-47217038	AG04450	lung:	fetal
11	chr16:47178723-47178773	Caco-2	colon:	n/a
12	chr16:47181961-47182011	GM12878	blood:	n/a
13	chr16:47164168-47164218	HL-60	blood:	n/a
14	chr16:47175842-47175892	AG10803	skin:	n/a
15	chr16:47176710-47176760	SK-N-MC	brain:	n/a
16	chr16:47214942-47214992	Hela-S3	cervix:	n/a
17	chr16:47175912-47175962	ProgFib	skin:	n/a
18	chr16:47178208-47178258	RPTEC	kidney:	n/a
19	chr16:47177480-47177530	PANC-1	pancreas:	n/a
20	chr16:47178208-47178258	HL-60	blood:	n/a
21	chr16:47216988-47217038	HUVEC	blood vessel:	n/a
22	chr16:47117092-47117142	HMEC	breast:	n/a
23	chr16:47178208-47178258	NHBE	bronchial:	n/a
24	chr16:47177603-47177653	GM12891	blood:	n/a
25	chr16:47181961-47182011	GM12891	blood:	n/a
26	chr16:47178070-47178120	AG09319	gingival:	n/a
27	chr16:47177175-47177225	SAEC	small airway:	n/a
28	chr16:47181961-47182011	AG09319	gingival:	n/a
29	chr16:47175842-47175892	HEEpiC	esophagus:	n/a
30	chr16:47178070-47178120	SK-N-SH_RA	brain:	n/a
31	chr16:47178723-47178773	HRPEpiC	eye:	n/a
32	chr16:47178723-47178773	U87	brain:	n/a
33	chr16:47178078-47178128	HEEpiC	esophagus:	n/a
34	chr16:47175936-47175986	NHBE	bronchial:	n/a
35	chr16:47178070-47178120	Caco-2	colon:	n/a
36	chr16:47177603-47177653	HCT-116	colon:	n/a
37	chr16:47117092-47117142	PrEC	prostate:	n/a
38	chr16:47178359-47178409	AoSMC	blood vessel:	n/a
39	chr16:47178359-47178409	AG09309	skin:	n/a
40	chr16:47175936-47175986	AG04449	skin:	fetal
41	chr16:47164168-47164218	SK-N-SH_RA	brain:	n/a
42	chr16:47173093-47173143	HIPEpiC	eye:	n/a
43	chr16:47175936-47175986	BE2_C	brain:	n/a
44	chr16:47178359-47178409	ECC-1	luminal epithelium:	n/a
45	chr16:47178078-47178128	PFSK-1	brain:	n/a
46	chr16:47178067-47178117	HUVEC	blood vessel:	n/a
47	chr16:47177175-47177225	ProgFib	skin:	n/a
48	chr16:47216988-47217038	PFSK-1	brain:	n/a
49	chr16:47175936-47175986	HAEpiC	amniotic membrane:	n/a
50	chr16:47173093-47173143	NHBE	bronchial:	n/a

(count:66 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr16:47171642..47174584-chr16:47493767..47496687,2	K562	blood:
2	chr16:47178986..47180526-chr16:47182698..47184295,2	K562	blood:
3	chr16:47201430..47205164-chr16:47207074..47210552,4	K562	blood:
4	chr16:47114863..47118029-chr16:47121766..47124133,3	K562	blood:
5	chr16:47174837..47177337-chr16:47189035..47191316,2	K562	blood:
6	chr16:47071055..47073725-chr16:47087478..47089914,2	K562	blood:
7	chr16:47116484..47118029-chr16:47121766..47123830,2	K562	blood:
8	chr16:47006185..47008137-chr16:47174529..47176605,2	K562	blood:
9	chr16:47189381..47191014-chr16:47191815..47193762,2	K562	blood:
10	chr16:47155510..47158192-chr16:47174850..47176528,2	K562	blood:
11	chr16:47177383..47180950-chr16:47184423..47188537,5	K562	blood:
12	chr16:47189381..47191014-chr16:47191815..47193762,2	K562	blood:
13	chr16:47175524..47179141-chr16:47493736..47496005,3	MCF-7	breast:
14	chr16:47136112..47138156-chr16:47139156..47141395,2	K562	blood:
15	chr16:47102804..47105348-chr16:47108276..47109997,2	K562	blood:
16	chr16:47175627..47176240-chr16:48199483..48200032,2	MCF-7	breast:
17	chr16:47201430..47205164-chr16:47207074..47210552,4	K562	blood:
18	chr16:47176370..47177924-chr16:47205584..47208161,2	MCF-7	breast:
19	chr16:47071376..47072506-chr16:47175620..47176296,3	K562	blood:
20	chr16:47114863..47118029-chr16:47121766..47124133,3	K562	blood:
21	chr16:47116484..47118029-chr16:47121766..47123830,2	K562	blood:
22	chr16:47184664..47186977-chr16:47194583..47196786,2	K562	blood:
23	chr16:47093709..47095926-chr16:47097350..47100461,3	K562	blood:
24	chr16:47151336..47152923-chr16:48188531..48190153,2	K562	blood:
25	chr16:47141593..47145551-chr16:47150754..47154001,3	K562	blood:
26	chr16:47109054..47112111-chr16:47113966..47116275,3	K562	blood:
27	chr1:8938804..8939443-chr16:47177378..47177897,2	Hela-S3	cervix:
28	chr16:47175994..47177897-chr16:48278487..48280949,2	MCF-7	breast:
29	chr16:47178385..47180317-chr16:47705518..47707688,2	K562	blood:
30	chr16:47203225..47205164-chr16:47207074..47209665,2	K562	blood:
31	chr16:47175296..47177509-chr16:48190040..48191217,7	MCF-7	breast:
32	chr16:47149538..47152356-chr16:47176160..47177758,2	MCF-7	breast:
33	chr16:47005815..47008447-chr16:47177298..47179122,2	K562	blood:
34	chr16:47094426..47096201-chr16:47098961..47101014,2	K562	blood:
35	chr16:47174005..47175581-chr16:47176201..47178952,2	MCF-7	breast:
36	chr16:47233470..47235990-chr16:47244208..47246996,2	K562	blood:
37	chr16:47180495..47185251-chr16:47187387..47190587,4	K562	blood:
38	chr16:47177500..47180441-chr16:47180510..47182693,2	K562	blood:
39	chr16:47094426..47096201-chr16:47098961..47101014,2	K562	blood:
40	chr16:47233614..47236128-chr16:47259100..47261091,2	K562	blood:
41	chr16:47178986..47180526-chr16:47182698..47184295,2	K562	blood:
42	chr16:47203225..47205164-chr16:47207074..47209665,2	K562	blood:
43	chr16:47144717..47146770-chr16:47176377..47178573,2	K562	blood:
44	chr16:47093709..47095926-chr16:47097350..47100461,3	K562	blood:
45	chr16:47184664..47186977-chr16:47194583..47196786,2	K562	blood:
46	chr16:47189136..47190025-chr20:45802278..45803128,2	MCF-7	breast:
47	chr16:47176885..47177462-chr16:47479483..47480444,2	K562	blood:
48	chr16:47102804..47105348-chr16:47108276..47109997,2	K562	blood:
49	chr16:47109054..47112111-chr16:47113966..47116275,3	K562	blood:
50	chr16:47174790..47177797-chr16:47493413..47496816,5	K562	blood:

(count:9 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PHKB-3	chr16:47230222-47230630	ENSG00000260744.1
2	lnc-GPT2-11	chr16:47211652-47211793	l_1316_chr16:47211651-47213507_testes
3	lnc-GPT2-10	chr16:47185464-47185705	NONHSAT142284
4	lnc-GPT2-3	chr16:47187543-47187707	NONHSAT142282
5	lnc-GPT2-3	chr16:47177999-47178405	NONHSAT142282
6	lnc-GPT2-3	chr16:47216667-47217006	NONHSAT142282
7	lnc-GPT2-3	chr16:47195460-47195501	NONHSAT142282
8	lnc-GPT2-11	chr16:47213203-47213513	l_1316_chr16:47211651-47213507_testes
9	lnc-GPT2-3	chr16:47191466-47191515	NONHSAT142282

No data

(count:5 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	NETO2	hsa-miR-20a-5p	chr16:47116059-47116081
2	NETO2	hsa-miR-21-5p	chr16:47115813-47115831
3	NETO2	hsa-miR-20a-5p	chr16:47116042-47116066
4	NETO2	hsa-miR-1	chr16:47116733-47116754
5	ITFG1	hsa-miR-23b-3p	chr16:47189629-47189649

Variant related genes	Relation type
ENSG00000260281	TF binding region
NETO2	TF binding region
ENSG00000238834	TF binding region
RPL23AP72	TF binding region
ENSG00000260744	TF binding region
ENSG00000260281	CpG island
NETO2	CpG island
ENSG00000238834	CpG island
RPL23AP72	CpG island
ENSG00000260744	CpG island
ENSG00000230679	chromatin interactions
ENSG00000260281	chromatin interactions
ENSG00000239840	chromatin interactions
ENSG00000069345	chromatin interactions
ENSG00000121270	chromatin interactions
ENSG00000171208	chromatin interactions
ENSG00000238834	chromatin interactions
ENSG00000102893	chromatin interactions
ENSG00000140798	chromatin interactions
ENSG00000074800	chromatin interactions
ENSG00000261173	chromatin interactions
ENSG00000129636	chromatin interactions

Extended variants
information (count: 4693 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:4693 , 50 per page) page: 1 2 3 4 5 6 7 ... 94

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7189807	chr16:47083332-47083333	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs553481004	chr16:47083344-47083345	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs571782250	chr16:47083391-47083392	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs545800251	chr16:47083397-47083398	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs557429316	chr16:47083419-47083420	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs142215578	chr16:47083544-47083545	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs7199379	chr16:47083609-47083610	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs369790619	chr16:47083623-47083624	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs76736421	chr16:47083673-47083674	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs575119313	chr16:47083745-47083746	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs12445492	chr16:47083786-47083787	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs150781338	chr16:47083837-47083838	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs191767105	chr16:47083850-47083851	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs567628261	chr16:47083917-47083918	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs552549276	chr16:47083939-47083940	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs80147136	chr16:47083953-47083954	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs73534965	chr16:47083955-47083956	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs549702018	chr16:47083975-47083976	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs535291226	chr16:47084001-47084002	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs547157268	chr16:47084005-47084006	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs182434021	chr16:47084057-47084058	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs139137113	chr16:47084058-47084059	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs187901893	chr16:47084068-47084069	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs568733097	chr16:47084077-47084078	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs529605414	chr16:47084147-47084148	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs539116540	chr16:47084194-47084195	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs557831715	chr16:47084242-47084243	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs575995220	chr16:47084288-47084289	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs548478135	chr16:47084297-47084298	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs372782456	chr16:47084315-47084316	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs556924421	chr16:47084334-47084335	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs11247542	chr16:47084352-47084353	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs542456441	chr16:47084366-47084367	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs560625778	chr16:47084367-47084368	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs557439273	chr16:47084430-47084431	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs546025219	chr16:47084447-47084448	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs570228261	chr16:47084453-47084454	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs564591316	chr16:47084470-47084471	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs145156313	chr16:47084502-47084503	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs549738748	chr16:47084514-47084515	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs561665932	chr16:47084528-47084529	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs71380984	chr16:47084535-47084536	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs147579246	chr16:47084580-47084581	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs547193955	chr16:47084628-47084629	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs111734603	chr16:47084639-47084640	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs112807502	chr16:47084694-47084695	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs111499838	chr16:47084749-47084750	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs397749084	chr16:47084767-47084768	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs201403842	chr16:47084768-47084769	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs397763742	chr16:47084769-47084770	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Wilms tumour	21544195	CNVD
Cancer	20164920	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Renal cell carcinoma	18765545	CNVD
Sudden cardiac death	19188705	CNVD
Multiple myeloma	16616336	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	21364760	CNVD
Ewing''s sarcoma	17952124	CNVD
Myelofibrosis	22110671	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Bladder cancer	21909424	CNVD
Colorectal cancer	19359472	CNVD
Olfactory neuroblastoma	18408657	CNVD
Prostate cancer	16461572	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22522925	CNVD
Prostate cancer	22341455	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:1813 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:47072400-47096800	Weak transcription	Right Atrium	heart
2	chr16:47078800-47084000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
3	chr16:47082400-47083600	Weak transcription	Fetal Muscle Leg	muscle
4	chr16:47082800-47093800	Weak transcription	Spleen	Spleen
5	chr16:47083400-47083600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
6	chr16:47083600-47083800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr16:47083800-47084000	Enhancers	Fetal Muscle Leg	muscle
8	chr16:47083800-47084600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr16:47083800-47085400	Bivalent Enhancer	HepG2	liver
10	chr16:47084000-47086600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
11	chr16:47084600-47085200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
12	chr16:47085200-47085400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr16:47086600-47087200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
14	chr16:47086600-47087800	Bivalent Enhancer	HepG2	liver
15	chr16:47086800-47087000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr16:47087000-47093200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr16:47087200-47087600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
18	chr16:47087600-47088200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
19	chr16:47087800-47088000	Flanking Bivalent TSS/Enh	HepG2	liver
20	chr16:47088000-47088200	Bivalent Enhancer	HepG2	liver
21	chr16:47088200-47088400	Flanking Bivalent TSS/Enh	HepG2	liver
22	chr16:47088200-47091400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
23	chr16:47088400-47089000	Bivalent Enhancer	HepG2	liver
24	chr16:47089000-47091400	Enhancers	HepG2	liver
25	chr16:47089400-47089800	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr16:47089800-47091000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr16:47090800-47091000	Enhancers	Brain Germinal Matrix	brain
28	chr16:47091000-47091200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr16:47091000-47091400	Active TSS	Breast Myoepithelial Primary Cells	Breast
30	chr16:47091000-47091400	Enhancers	Pancreas	Pancrea
31	chr16:47091000-47092000	Weak transcription	Brain Germinal Matrix	brain
32	chr16:47091200-47091400	Bivalent Enhancer	NHLF	lung
33	chr16:47091200-47091600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr16:47091400-47091800	Flanking Active TSS	HepG2	liver
35	chr16:47091400-47093400	Enhancers	Rectal Mucosa Donor 29	rectum
36	chr16:47091400-47093600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
37	chr16:47091600-47091800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr16:47091800-47092400	Enhancers	HepG2	liver
39	chr16:47091800-47093400	Enhancers	Colonic Mucosa	Colon
40	chr16:47092000-47092200	Enhancers	Brain Germinal Matrix	brain
41	chr16:47092200-47092600	Enhancers	Duodenum Mucosa	Duodenum
42	chr16:47092200-47092800	Weak transcription	Brain Germinal Matrix	brain
43	chr16:47092400-47093200	Flanking Active TSS	HepG2	liver
44	chr16:47092600-47093400	Enhancers	Rectal Mucosa Donor 31	rectum
45	chr16:47092800-47093000	Enhancers	Brain Germinal Matrix	brain
46	chr16:47092800-47093600	Enhancers	HMEC	breast
47	chr16:47092800-47093600	Enhancers	NHEK	skin
48	chr16:47093200-47093400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
49	chr16:47093200-47093800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr16:47093200-47096000	Enhancers	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links